Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11643 | 30807482 | J Acquir Immune Defic Syndr | Etiology and Severity of Liver Disease in HIV-Positive Patients With Suspected NAFLD: Lessons From a Cohort With Available Liver Biopsies. | 2019 | Details |
| A11644 | 30807444 | Eur J Gastroenterol Hepatol | The clinical usefulness of elastography in the evaluation of nonalcoholic fatty liver disease patients: A biopsy-controlled study. | 2019 | Details |
| A11645 | 30807179 | J Proteome Res | Proteomic Analysis Reveals Novel Mechanisms by Which Polychlorinated Biphenyls Compromise the Liver Promoting Diet-Induced Steatohepatitis. | 2019 | Details |
| A11646 | 30806344 | Br J Nutr | Spirulina supplementation in a mouse model of diet-induced liver fibrosis reduced the pro-inflammatory response of splenocytes. | 2019 | Details |
| A11649 | 30805949 | Hepatology | NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11652 | 30803948 | BMJ Open | Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study. | 2019 | Details |
| A11653 | 30803502 | Nutr Res | Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease. | 2018 | Details |
| A11663 | 30798598 | J Agric Food Chem | Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. | 2019 | Details |
| A11665 | 30797053 | J Hepatol | Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. | 2019 | Details |
| A11678 | 30793550 | Diabetes Metab J | Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis. | 2019 | Details |
| A11686 | 30791767 | Expert Rev Gastroenterol Hepatol | Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. | 2019 | Details |
| A11696 | 30788556 | Abdom Radiol (NY) | Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2019 | Details |
| A11697 | 30788048 | World J Diabetes | SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11701 | 30787418 | Sci Rep | Transcriptional regulation of Hepatic Stellate Cell activation in NASH. | 2019 | Details |
| A11706 | 30784251 | Minerva Med | Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. | 2019 | Details |
| A11707 | 30783901 | Hepatol Int | End-points for drug treatment in NASH. | 2019 | Details |
| A11714 | 30780126 | Pharmacol Rep | Evaluation of metformin therapy using controlled attenuation parameter and transient elastography in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A11715 | 30779990 | Clin Gastroenterol Hepatol | Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A11719 | 30778201 | Cell Death Differ | The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression. | 2019 | Details |
| A11725 | 30775610 | Arch Med Sci Atheroscler Dis | Non-invasive diagnosis of steatosis, inflammatory changes and liver fibrosis in patients with non-alcoholic fatty liver diseases. Pilot study. | 2018 | Details |
| A11727 | 30774801 | Gastroenterol Hepatol Bed Bench | Comparing different non-invasive methods in assessment of the effects of curcumin on hepatic fibrosis in patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A11729 | 30774269 | World J Gastroenterol | Iron and liver fibrosis: Mechanistic and clinical aspects. | 2019 | Details |
| A11733 | 30772307 | EBioMedicine | Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A11734 | 30772256 | Mol Metab | Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. | 2019 | Details |
| A11744 | 30769007 | J Hepatol | The degree of hepatic steatosis associates with impaired cardiac and autonomic function. | 2019 | Details |
| A11753 | 30765936 | J Clin Exp Hepatol | Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker. | 2018 | Details |
| A11754 | 30765935 | J Clin Exp Hepatol | Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease. | 2017 | Details |
| A11755 | 30765934 | J Clin Exp Hepatol | Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients. | 2018 | Details |
| A11757 | 30763931 | Cerebrovasc Dis | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients. | 2019 | Details |
| A11759 | 30763486 | Vopr Pitan | [Effect of quercetin on morphological changes in nonalcoholic fatty liver disease in high fructose-fed rats]. | 2018 | Details |
| A11765 | 30761559 | Aliment Pharmacol Ther | Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. | 2019 | Details |
| A11766 | 32598624 | Ter Arkh | [Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis]. | 2019 | Details |
| A11767 | 30759431 | Ann Nutr Metab | Low Levels of Serum β-Carotene and β-Carotene/Retinol Ratio Are Associated with Histological Severity in Nonalcoholic Fatty Liver Disease Patients. | 2019 | Details |
| A11768 | 30759275 | Mol Genet Genomics | Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model. | 2019 | Details |
| A11774 | 30755685 | Sci Rep | Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. | 2019 | Details |
| A11780 | 30746959 | Rev Esp Enferm Dig | Comparative study of overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11784 | 30745819 | Int J Biol Sci | Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates. | 2019 | Details |
| A11786 | 30745416 | J Pharmacol Exp Ther | RLA8-A New and Highly Effective Quadruple PPAR-α/γ/δ and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis. | 2019 | Details |
| A11787 | 30744663 | BMC Res Notes | Regular exposure to non-burning ultraviolet radiation reduces signs of non-alcoholic fatty liver disease in mature adult mice fed a high fat diet: results of a pilot study. | 2019 | Details |
| A11789 | 30744560 | BMC Gastroenterol | Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis. | 2019 | Details |
| A11791 | 30743004 | Clin Gastroenterol Hepatol | American Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults. | 2019 | Details |
| A11799 | 30735855 | Biochim Biophys Acta Mol Cell Biol Lipids | Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling. | 2019 | Details |
| A11800 | 30735854 | Biochim Biophys Acta Mol Cell Biol Lipids | iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. | 2019 | Details |
| A11805 | 30732664 | Proc Nutr Soc | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. | 2019 | Details |
| A11807 | 30732129 | Medicine (Baltimore) | Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11808 | 30731283 | Atherosclerosis | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | 2019 | Details |
| A11826 | 30719457 | J Immunol Res | The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD. | 2019 | Details |
| A11830 | 30717274 | Metabolites | The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD). | 2019 | Details |
| A11832 | 30716793 | Hepatol Res | Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11833 | 30716478 | Clin Gastroenterol Hepatol | Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation. | 2019 | Details |
| A11839 | 30711707 | Toxicology | The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A11841 | 30711404 | J Hepatol | Autophagy in liver diseases: Time for translation? | 2019 | Details |
| A11849 | 30708111 | Clin Gastroenterol Hepatol | Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. | 2019 | Details |
| A11852 | 30708071 | Diabetes Metab | Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications. | 2019 | Details |
| A11855 | 30707282 | J Gastroenterol | Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis. | 2019 | Details |
| A11860 | 30705893 | World J Clin Cases | Interventions to improve sarcopenia in cirrhosis: A systematic review. | 2019 | Details |
| A11861 | 30705715 | World J Hepatol | Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. | 2019 | Details |
| A11865 | 30704899 | Mol Cell | Pacer Is a Mediator of mTORC1 and GSK3-TIP60 Signaling in Regulation of Autophagosome Maturation and Lipid Metabolism. | 2019 | Details |
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11868 | 30703747 | J Inorg Biochem | Liver pathology in Wilson's disease: From copper overload to cirrhosis. | 2019 | Details |
| A11871 | 30701940 | Ter Arkh | The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. | 2018 | Details |
| A11874 | 30701776 | Ter Arkh | Intrahepatic cholestasis in nonalcoholic fatty liver disease. | 2018 | Details |
| A11878 | 30700810 | Sci Rep | Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. | 2019 | Details |
| A11885 | 30695042 | PLoS One | Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease. | 2019 | Details |
| A11887 | 30694866 | Am J Gastroenterol | Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study. | 2019 | Details |
| A11889 | 30694445 | Hepatol Int | Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. | 2019 | Details |
| A11892 | 30691985 | Endocrinol Diabetes Nutr (Engl Ed) | Role of neuropeptide Y gene variant (rs161477) in liver histology in obese patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11895 | 30690636 | Poult Sci | Interactions between the cecal microbiota and non-alcoholic steatohepatitis using laying hens as the model. | 2019 | Details |
| A11899 | 30689971 | Gastroenterology | Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11900 | 30689650 | PLoS One | Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A11901 | 30687994 | Diabetes Obes Metab | Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial. | 2019 | Details |
| A11905 | 30686780 | Cell Mol Gastroenterol Hepatol | Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism. | 2018 | Details |
| A11910 | 30684890 | Redox Biol | Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. | 2018 | Details |
| A11911 | 30684076 | Dig Dis Sci | Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus. | 2019 | Details |
| A11914 | 30683615 | Dig Liver Dis | Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2019 | Details |
| A11915 | 30683512 | Surg Obes Relat Dis | Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. | 2018 | Details |
| A11917 | 30682878 | Medicina (Kaunas) | Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A11919 | 30682184 | PLoS One | Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study. | 2019 | Details |
| A11923 | 30680827 | Int J Exp Pathol | Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model. | 2019 | Details |
| A11924 | 30680167 | Food Sci Nutr | Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A11927 | 30679317 | Oncologist | Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study. | 2019 | Details |
| A11928 | 30678506 | J Int Med Res | Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease. | 2019 | Details |
| A11935 | 30674511 | Can Fam Physician | Omega-3 for nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11940 | 30673619 | Cell Rep | Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. | 2019 | Details |
| A11941 | 30673340 | AJR Am J Roentgenol | Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic 18F-FDG PET. | 2019 | Details |
| A11950 | 30670907 | World J Gastroenterol | Current status, problems, and perspectives of non-alcoholic fatty liver disease research. | 2019 | Details |
| A11955 | 30669332 | Nutrients | Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid. | 2019 | Details |
| A11956 | 30668889 | J Gastroenterol Hepatol | Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis. | 2019 | Details |
| A11957 | 30668625 | Acta Biochim Biophys Sin (Shanghai) | Chronic intermittent hypoxia accelerates liver fibrosis in rats with combined hypoxia and nonalcoholic steatohepatitis via angiogenesis rather than endoplasmic reticulum stress. | 2019 | Details |
| A11960 | 30667551 | J Gastroenterol Hepatol | Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A11968 | 30663454 | Scand J Gastroenterol | Predictive value of the red blood cell distribution width-to-platelet ratio for hepatic fibrosis. | 2019 | Details |
| A11971 | 30661332 | J Exerc Nutrition Biochem | Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults. | 2018 | Details |
| A11976 | 30660725 | Gastroenterology | Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11979 | 30659533 | Curr Pharm Des | Genetics of Nonalcoholic Fatty Liver Disease: A 2018 Update. | 2018 | Details |
| A11980 | 30659241 | Sci Rep | A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models. | 2019 | Details |
| A11981 | 30658997 | Gut | Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. | 2019 | Details |
| A11982 | 30658730 | J Hepatol | Fibrosis and alcohol-related liver disease. | 2019 | Details |
| A11984 | 30658483 | Nutrients | A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. | 2019 | Details |
| A11986 | 30658094 | Pharmacol Res | Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis. | 2019 | Details |